Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.36B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$1.04B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$951M |
| 4 |
Airbnb
ABNB
|
+$942M |
| 5 |
Kenvue
KVUE
|
+$704M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.7B |
| 2 |
Uber
UBER
|
+$901M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$855M |
| 4 |
Illumina
ILMN
|
+$674M |
| 5 |
iShares Russell 1000 Value ETF
IWD
|
+$637M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.54% |
| 2 | Healthcare | 10.41% |
| 3 | Financials | 10.2% |
| 4 | Consumer Discretionary | 8.92% |
| 5 | Industrials | 6.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4926
iShares MSCI New Zealand ETF
ENZL
$82.9M
| $612K | ﹤0.01% |
13,824
-1,400
| -9% | -$65.6K |
|
|
ALPN
4927
DELISTED
Alpine Immune Sciences Inc
ALPN
| $612K | ﹤0.01% |
53,473
+3,269
| +7% | +$40.2K |
|
4928
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
$2.92B
| $611K | ﹤0.01% |
18,142
+3,592
| +25% | +$128K |
|
|
RPTX
4929
DELISTED
Repare Therapeutics
RPTX
| $608K | ﹤0.01% |
50,322
+1,018
| +2% | +$10.5K |
|
4930
Outdoor Holding Co
POWW
$247M
| $605K | ﹤0.01% |
299,525
-33,680
| -10% | -$70.7K |
|
4931
Townsquare Media
TSQ
$118M
| $604K | ﹤0.01% |
69,213
-5,632
| -8% | -$58.4K |
|
4932
eGain
EGAN
$201M
| $601K | ﹤0.01% |
98,101
+78,910
| +411% | +$532K |
|
|
PPIH
4933
Perma-Pipe International
PPIH
$215M
| $601K | ﹤0.01% |
73,533
+3,074
| +4% | +$26.4K |
|
|
LNAI
4934
Lunai Bioworks
LNAI
$10.9M
| $598K | ﹤0.01% |
1,671
+1,091
| +188% | +$166K |
|
4935
Blue Ridge Bankshares
BRBS
$332M
| $597K | ﹤0.01% |
132,069
+94,557
| +252% | +$744K |
|
|
PCF
4936
High Income Securities Fund
PCF
$99.9M
| $596K | ﹤0.01% |
96,258
+12,001
| +14% | +$78.3K |
|
4937
ADC Therapeutics
ADCT
$144M
| $596K | ﹤0.01% |
664,027
+11,249
| +2% | +$15K |
|
4938
Nuvation Bio
NUVB
$2.32B
| $596K | ﹤0.01% |
444,498
-169,736
| -28% | -$283K |
|
4939
Lightwave Logic
LWLG
$1.25B
| $596K | ﹤0.01% |
133,234
-36,479
| -21% | -$233K |
|
4940
ClearPoint Neuro
CLPT
$433M
| $595K | ﹤0.01% |
118,694
+49,156
| +71% | +$293K |
|
|
BCTX
4941
Briacell Therapeutics
BCTX
$31.7M
| $594K | ﹤0.01% |
633
+131
| +26% | +$128K |
|
4942
Bowman Consulting
BWMN
$477M
| $594K | ﹤0.01% |
21,177
-50,868
| -71% | -$1.55M |
|
4943
Franklin Financial Services
FRAF
$280M
| $593K | ﹤0.01% |
20,805
+676
| +3% | +$19.6K |
|
4944
Peoples Financial Services
PFIS
$707M
| $591K | ﹤0.01% |
14,727
-536
| -4% | -$24.1K |
|
4945
First Business Financial Services
FBIZ
$595M
| $590K | ﹤0.01% |
19,653
-1,884
| -9% | -$59.5K |
|
|
QVCGA
4946
DELISTED
QVC Group Inc Series A
QVCGA
| $589K | ﹤0.01% |
19,405
-5,444
| -22% | -$230K |
|
|
DFAI
4947
Dimensional International Core Equity Market ETF
DFAI
$18B
| $588K | ﹤0.01% |
22,523
+3,975
| +21% | +$108K |
|
|
YMAB
4948
DELISTED
Y-mAbs Therapeutics
YMAB
| $588K | ﹤0.01% |
107,874
-22,748
| -17% | -$132K |
|
|
PIM
4949
Franklin Master Intermediate Income Trust
PIM
$151M
| $584K | ﹤0.01% |
193,264
+29,092
| +18% | +$91.4K |
|
|
FAZ
4950
Direxion Daily Financial Bear 3x ETF
FAZ
$86.7M
| $584K | ﹤0.01% |
2,918
+2,213
| +314% | +$397K |
|
Similar funds
Morgan Stanley's Q3 2023 Portfolio in Review
As of Q3 2023, Morgan Stanley held 7,879 positions worth $983B, down 3.1% from $1.01T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Morgan Stanley's Q3 2023 filing shows 220 new, 3,247 increased, 3,221 reduced and 253 closed positions. Its largest new stake was TKO Group: 3,583,743 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.7B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2023 buy was TKO Group: 3,583,743 shares worth $301M.
- Morgan Stanley added most to iShares Core S&P 500 ETF in Q3 2023, an estimated $2.36B increase.
- Morgan Stanley's biggest Q3 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.7B.
- Morgan Stanley fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $432M.
- Morgan Stanley's ten largest holdings make up 18% of its $983B portfolio in Q3 2023.
- Morgan Stanley opened 220 new positions and closed 253 in Q3 2023.
- Morgan Stanley's portfolio value fell 3.1% quarter-over-quarter to $983B.
Based on Morgan Stanley's 13F filing for Q3 2023, filed 15 Nov 2023.